Best of cannabinoid science this week...
In patients with hypertension, a single dose of either CBD or a novel CBD capsule reduced diastolic blood pressure & mean arterial pressure Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study https://www.mdpi.com/1424-8247/16/5/645
A case study of a cat with osteoarthritis where full spectrum cannabis oil for 30 days helped with the pain A case report of CBD and THC as analgesic therapy in a cat with chronic osteoarthritic pain https://pubmed.ncbi.nlm.nih.gov/37002652/
A review of using CBD for the cognitive impairment arising from psychiatric & neurological illnesses Use of cannabidiol (CBD) for the treatment of cognitive impairment in psychiatric and neurological illness: A narrative review https://pubmed.ncbi.nlm.nih.gov/37126037/
In a rat model of alcohol use disorder, CBD inhibited the development of tolerance to alcohol Cannabidiol as a Modulator of the Development of Alcohol Tolerance in Rats https://pubmed.ncbi.nlm.nih.gov/37049542/
In mice, CBD increased good bacteria in the gut as well as displaying potential benefits for cardiovascular protection Multi-Omics Reveals the Effects of Cannabidiol on Gut Microbiota and Metabolic Phenotypes https://pubmed.ncbi.nlm.nih.gov/37098174/